| KURA ONCOLOGY DL-,0001 | 
| USA | 
| Gesundheit | 
| US50127T1097 / A143UH | 
| KUR (Frankfurt) / KURA (NASDAQ) | 
| FRA:KUR, ETR:KUR, KUR:GR, NASDAQ:KURA | 
| - | 
| https://kuraoncology.com/ | 
| 
            Kura Oncology Inc. is a clinical-stage biopharmace..
             >Volltext..  | 
      
| 773.86 Mio. EUR | 
| 252.79 Mio. EUR | 
| 72.3 Mio. EUR | 
| -189.97 Mio. EUR | 
| -171.17 Mio. EUR | 
| -1.96 EUR | 
| 16.91 Mio. EUR | 
| 71.14 Mio. EUR | 
| 108.51 Mio. EUR | 
| 5.89 | 
| - | 
| 1.36% | 
| - | 
| - | 
| - | 
| - | 
| KURA ONCOLOGY | 
| 04.11.25 | 
      
  | 
||||
      
  | 
||||
      
  | 
||||
      
  | 
||||
      
  | 
||||
      
  | 
||||
      
  | 
||||
      
  | 
||||
      
  |